Patient and Public Involvement in Pharmacoepidemiological Research: An Environmental Scan of an Emerging Area
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70080 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Rigoureau Julie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France. Hauptthemen laut MEDLINE: Pharmacoepidemiology, Patient Participation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de Sécurité du Médicament et des Produits de Santé.
Abstract (Originalsprache)
Background
Patient and public involvement (PPI) in research is required to improve the relevance, feasibility, and interpretability. However, research on PPIs in pharmacoepidemiology (PE) is still limited. This study aimed to provide an overview of PPI implementation in pharmacoepidemiology through an environmental scan.
Methods
The environmental scan combined systematic reviews and expert interviews. A systematic review was conducted in MEDLINE, EMBASE, and the Cochrane Library from January 1, 2010, to June 30, 2023, to identify PE studies in which PPIs were mentioned. An additional review covered British Medical Journal's ( BMJ ) original articles from January 1, 2019, to June 30, 2023, via a similar method. In parallel, a cross‐sectional study was conducted with a standardized questionnaire for French PE research teams, involving interviews via videoconference.
Results
We identified 3615 references for screening, among which 232 were selected for full‐text screening. However, no studies have reported the use of PPIs in PE studies. The additional BMJ review identified 1058 references, 74 of which met the full‐text selection criteria, and eight were included. Of 13 French PE research teams surveyed, three had prior PPI experience, and 12 affirmed the relevance of PPI in PE. The respondents identified barriers such as PE's complexity ( n = 9). They suggested training for patients ( n = 9) and collaboration with specialist teams ( n = 5) to facilitate PPI.
Conclusion
Our environmental scan highlighted the emergence and relevance of PPIs in PE studies, even though they are still uncommon. Tools are needed to acculture and assist PE researchers in engaging in PPIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France.
- Hospices Civils de Lyon, Service Des Données de Santé, Lyon, France.
- Hospices Civils de Lyon, Service de Recherche et épidémiologie Cliniques, Lyon, France.
ORCID-Profile: Rigoureau Julie, Havet Anaïs, Haesebaert Julie, Viprey Marie
Förderung
- Agence Nationale de Sécurité du Médicament et des Produits de Santé
Zitieren
APA
Julie, R., Yael, B., Anaïs, H., Anne, T., Julie, H., & Marie, V. (2025). Patient and Public Involvement in Pharmacoepidemiological Research: An Environmental Scan of an Emerging Area. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70080
Vancouver
Julie R, Yael B, Anaïs H, Anne T, Julie H, Marie V. Patient and Public Involvement in Pharmacoepidemiological Research: An Environmental Scan of an Emerging Area. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70080
BibTeX
@article{Julie2025,
author = {Julie, Rigoureau and Yael, Busnel and Anaïs, Havet and Anne, Termoz and Julie, Haesebaert and Marie, Viprey},
title = {Patient and Public Involvement in Pharmacoepidemiological Research: An Environmental Scan of an Emerging Area},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70080}
}
EUVIMED